nodes	percent_of_prediction	percent_of_DWPC	metapath
Metyrosine—Ibuprofen—Procarbazine—brain cancer	0.771	1	CrCrCtD
Metyrosine—TH—fourth ventricle—brain cancer	0.0408	0.285	CbGeAlD
Metyrosine—TH—cerebellar cortex—brain cancer	0.0203	0.142	CbGeAlD
Metyrosine—TH—cranial nerve—brain cancer	0.0145	0.101	CbGeAlD
Metyrosine—TH—pons—brain cancer	0.0144	0.1	CbGeAlD
Metyrosine—TH—Dopaminergic Neurogenesis—OTX2—brain cancer	0.012	0.279	CbGpPWpGaD
Metyrosine—TH—telencephalic ventricle—brain cancer	0.0118	0.0825	CbGeAlD
Metyrosine—TH—ganglion—brain cancer	0.00736	0.0514	CbGeAlD
Metyrosine—TH—blood vessel—brain cancer	0.00585	0.0408	CbGeAlD
Metyrosine—TH—hindbrain—brain cancer	0.00558	0.039	CbGeAlD
Metyrosine—TH—Dopaminergic Neurogenesis—GLI2—brain cancer	0.00521	0.121	CbGpPWpGaD
Metyrosine—TH—Dopaminergic Neurogenesis—GLI1—brain cancer	0.0049	0.114	CbGpPWpGaD
Metyrosine—TH—Dopaminergic Neurogenesis—SHH—brain cancer	0.00354	0.0825	CbGpPWpGaD
Metyrosine—TH—brainstem—brain cancer	0.0032	0.0223	CbGeAlD
Metyrosine—TH—telencephalon—brain cancer	0.00284	0.0198	CbGeAlD
Metyrosine—TH—pituitary gland—brain cancer	0.00231	0.0161	CbGeAlD
Metyrosine—TH—medulla oblongata—brain cancer	0.00223	0.0156	CbGeAlD
Metyrosine—TH—midbrain—brain cancer	0.00204	0.0142	CbGeAlD
Metyrosine—TH—spinal cord—brain cancer	0.00199	0.0139	CbGeAlD
Metyrosine—Disorientation—Lomustine—brain cancer	0.00187	0.0455	CcSEcCtD
Metyrosine—TH—Parkinsons Disease Pathway—CCNE1—brain cancer	0.00186	0.0435	CbGpPWpGaD
Metyrosine—TH—endocrine gland—brain cancer	0.00179	0.0125	CbGeAlD
Metyrosine—TH—SIDS Susceptibility Pathways—HES5—brain cancer	0.00178	0.0415	CbGpPWpGaD
Metyrosine—TH—head—brain cancer	0.00177	0.0123	CbGeAlD
Metyrosine—TH—central nervous system—brain cancer	0.00161	0.0113	CbGeAlD
Metyrosine—TH—cerebellum—brain cancer	0.00158	0.011	CbGeAlD
Metyrosine—TH—Circadian rythm related genes—NTRK3—brain cancer	0.0015	0.035	CbGpPWpGaD
Metyrosine—TH—brain—brain cancer	0.00128	0.00894	CbGeAlD
Metyrosine—TH—ATF-2 transcription factor network—HES1—brain cancer	0.00128	0.0299	CbGpPWpGaD
Metyrosine—Acetaminophen—CYP2C9—brain cancer	0.00126	0.627	CrCbGaD
Metyrosine—TH—ATF-2 transcription factor network—PDGFRA—brain cancer	0.00122	0.0284	CbGpPWpGaD
Metyrosine—Disorientation—Procarbazine—brain cancer	0.00119	0.0289	CcSEcCtD
Metyrosine—Extrapyramidal disorder—Temozolomide—brain cancer	0.00117	0.0286	CcSEcCtD
Metyrosine—Speech disorder—Carmustine—brain cancer	0.00106	0.0259	CcSEcCtD
Metyrosine—Speech disorder—Temozolomide—brain cancer	0.00103	0.025	CcSEcCtD
Metyrosine—TH—ATF-2 transcription factor network—CDK4—brain cancer	0.001	0.0234	CbGpPWpGaD
Metyrosine—TH—Dopaminergic Neurogenesis—STAT3—brain cancer	0.000962	0.0224	CbGpPWpGaD
Metyrosine—Disorientation—Hydroxyurea—brain cancer	0.000919	0.0224	CcSEcCtD
Metyrosine—Eosinophilia—Procarbazine—brain cancer	0.000909	0.0221	CcSEcCtD
Metyrosine—Thrombocytopenia—Lomustine—brain cancer	0.000805	0.0196	CcSEcCtD
Metyrosine—Haematuria—Procarbazine—brain cancer	0.00078	0.019	CcSEcCtD
Metyrosine—TH—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000757	0.0177	CbGpPWpGaD
Metyrosine—Swelling—Carmustine—brain cancer	0.000753	0.0183	CcSEcCtD
Metyrosine—Ibuprofen—CYP2C9—brain cancer	0.000747	0.373	CrCbGaD
Metyrosine—Hallucination—Procarbazine—brain cancer	0.000731	0.0178	CcSEcCtD
Metyrosine—Nasal congestion—Temozolomide—brain cancer	0.000705	0.0172	CcSEcCtD
Metyrosine—TH—AP-1 transcription factor network—CDKN2A—brain cancer	0.000669	0.0156	CbGpPWpGaD
Metyrosine—Dysuria—Hydroxyurea—brain cancer	0.000664	0.0162	CcSEcCtD
Metyrosine—TH—ATF-2 transcription factor network—CCND1—brain cancer	0.000649	0.0151	CbGpPWpGaD
Metyrosine—Tremor—Procarbazine—brain cancer	0.000599	0.0146	CcSEcCtD
Metyrosine—Anaemia—Procarbazine—brain cancer	0.000591	0.0144	CcSEcCtD
Metyrosine—TH—SIDS Susceptibility Pathways—HES1—brain cancer	0.000588	0.0137	CbGpPWpGaD
Metyrosine—Swelling—Etoposide—brain cancer	0.000582	0.0142	CcSEcCtD
Metyrosine—TH—AP-1 transcription factor network—IL2—brain cancer	0.00058	0.0135	CbGpPWpGaD
Metyrosine—Aspartate aminotransferase increased—Temozolomide—brain cancer	0.000578	0.0141	CcSEcCtD
Metyrosine—Hallucination—Hydroxyurea—brain cancer	0.000566	0.0138	CcSEcCtD
Metyrosine—TH—AP-1 transcription factor network—CCND1—brain cancer	0.000566	0.0132	CbGpPWpGaD
Metyrosine—TH—AP-1 transcription factor network—CTNNB1—brain cancer	0.00056	0.0131	CbGpPWpGaD
Metyrosine—Anxiety—Procarbazine—brain cancer	0.000543	0.0132	CcSEcCtD
Metyrosine—Dry mouth—Procarbazine—brain cancer	0.000532	0.013	CcSEcCtD
Metyrosine—Confusional state—Procarbazine—brain cancer	0.000526	0.0128	CcSEcCtD
Metyrosine—Vomiting—Lomustine—brain cancer	0.000523	0.0127	CcSEcCtD
Metyrosine—Dysuria—Temozolomide—brain cancer	0.000519	0.0126	CcSEcCtD
Metyrosine—Erectile dysfunction—Temozolomide—brain cancer	0.000511	0.0124	CcSEcCtD
Metyrosine—Thrombocytopenia—Procarbazine—brain cancer	0.000511	0.0124	CcSEcCtD
Metyrosine—TH—Circadian rythm related genes—SIRT1—brain cancer	0.000498	0.0116	CbGpPWpGaD
Metyrosine—Nausea—Lomustine—brain cancer	0.000488	0.0119	CcSEcCtD
Metyrosine—Insomnia—Procarbazine—brain cancer	0.000472	0.0115	CcSEcCtD
Metyrosine—Anaemia—Hydroxyurea—brain cancer	0.000457	0.0111	CcSEcCtD
Metyrosine—Hallucination—Carmustine—brain cancer	0.000457	0.0111	CcSEcCtD
Metyrosine—TH—AP-1 transcription factor network—MYC—brain cancer	0.000454	0.0106	CbGpPWpGaD
Metyrosine—Oedema peripheral—Carmustine—brain cancer	0.000453	0.011	CcSEcCtD
Metyrosine—Fatigue—Procarbazine—brain cancer	0.00045	0.011	CcSEcCtD
Metyrosine—Hallucination—Temozolomide—brain cancer	0.000442	0.0108	CcSEcCtD
Metyrosine—Oedema peripheral—Temozolomide—brain cancer	0.000438	0.0107	CcSEcCtD
Metyrosine—Feeling abnormal—Procarbazine—brain cancer	0.00043	0.0105	CcSEcCtD
Metyrosine—Gastrointestinal pain—Procarbazine—brain cancer	0.000427	0.0104	CcSEcCtD
Metyrosine—Urticaria—Procarbazine—brain cancer	0.000415	0.0101	CcSEcCtD
Metyrosine—Abdominal pain—Procarbazine—brain cancer	0.000413	0.01	CcSEcCtD
Metyrosine—Thrombocytopenia—Hydroxyurea—brain cancer	0.000395	0.00963	CcSEcCtD
Metyrosine—Hypersensitivity—Procarbazine—brain cancer	0.000385	0.00936	CcSEcCtD
Metyrosine—TH—Circadian rythm related genes—CDK4—brain cancer	0.000377	0.00878	CbGpPWpGaD
Metyrosine—Tremor—Carmustine—brain cancer	0.000375	0.00913	CcSEcCtD
Metyrosine—Asthenia—Procarbazine—brain cancer	0.000374	0.00912	CcSEcCtD
Metyrosine—TH—AP-1 transcription factor network—TP53—brain cancer	0.000373	0.00869	CbGpPWpGaD
Metyrosine—Anaemia—Carmustine—brain cancer	0.00037	0.009	CcSEcCtD
Metyrosine—Tremor—Temozolomide—brain cancer	0.000362	0.00882	CcSEcCtD
Metyrosine—Anaemia—Temozolomide—brain cancer	0.000357	0.0087	CcSEcCtD
Metyrosine—Diarrhoea—Procarbazine—brain cancer	0.000357	0.00869	CcSEcCtD
Metyrosine—Fatigue—Hydroxyurea—brain cancer	0.000348	0.00848	CcSEcCtD
Metyrosine—Anxiety—Carmustine—brain cancer	0.000339	0.00826	CcSEcCtD
Metyrosine—Feeling abnormal—Hydroxyurea—brain cancer	0.000333	0.0081	CcSEcCtD
Metyrosine—Vomiting—Procarbazine—brain cancer	0.000332	0.00808	CcSEcCtD
Metyrosine—Confusional state—Carmustine—brain cancer	0.000329	0.00802	CcSEcCtD
Metyrosine—Anxiety—Temozolomide—brain cancer	0.000328	0.00799	CcSEcCtD
Metyrosine—Headache—Procarbazine—brain cancer	0.000327	0.00796	CcSEcCtD
Metyrosine—Dry mouth—Temozolomide—brain cancer	0.000322	0.00784	CcSEcCtD
Metyrosine—Thrombocytopenia—Carmustine—brain cancer	0.00032	0.00778	CcSEcCtD
Metyrosine—Confusional state—Temozolomide—brain cancer	0.000318	0.00775	CcSEcCtD
Metyrosine—Nausea—Procarbazine—brain cancer	0.00031	0.00755	CcSEcCtD
Metyrosine—Thrombocytopenia—Temozolomide—brain cancer	0.000309	0.00752	CcSEcCtD
Metyrosine—Hypersensitivity—Hydroxyurea—brain cancer	0.000298	0.00724	CcSEcCtD
Metyrosine—Insomnia—Carmustine—brain cancer	0.000295	0.00719	CcSEcCtD
Metyrosine—TH—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.000295	0.00688	CbGpPWpGaD
Metyrosine—Asthenia—Hydroxyurea—brain cancer	0.00029	0.00705	CcSEcCtD
Metyrosine—Anaemia—Etoposide—brain cancer	0.000286	0.00696	CcSEcCtD
Metyrosine—Insomnia—Temozolomide—brain cancer	0.000285	0.00695	CcSEcCtD
Metyrosine—Diarrhoea—Hydroxyurea—brain cancer	0.000276	0.00673	CcSEcCtD
Metyrosine—Fatigue—Temozolomide—brain cancer	0.000272	0.00662	CcSEcCtD
Metyrosine—Feeling abnormal—Carmustine—brain cancer	0.000269	0.00655	CcSEcCtD
Metyrosine—Gastrointestinal pain—Carmustine—brain cancer	0.000267	0.0065	CcSEcCtD
Metyrosine—Feeling abnormal—Temozolomide—brain cancer	0.00026	0.00633	CcSEcCtD
Metyrosine—TH—SIDS Susceptibility Pathways—VEGFA—brain cancer	0.00026	0.00605	CbGpPWpGaD
Metyrosine—TH—Metabolism—CYP2C9—brain cancer	0.000259	0.00604	CbGpPWpGaD
Metyrosine—Abdominal pain—Carmustine—brain cancer	0.000258	0.00628	CcSEcCtD
Metyrosine—Gastrointestinal pain—Temozolomide—brain cancer	0.000258	0.00628	CcSEcCtD
Metyrosine—Vomiting—Hydroxyurea—brain cancer	0.000257	0.00625	CcSEcCtD
Metyrosine—Confusional state—Etoposide—brain cancer	0.000255	0.0062	CcSEcCtD
Metyrosine—Headache—Hydroxyurea—brain cancer	0.000253	0.00616	CcSEcCtD
Metyrosine—Urticaria—Temozolomide—brain cancer	0.000251	0.0061	CcSEcCtD
Metyrosine—Abdominal pain—Temozolomide—brain cancer	0.000249	0.00607	CcSEcCtD
Metyrosine—Thrombocytopenia—Etoposide—brain cancer	0.000247	0.00602	CcSEcCtD
Metyrosine—Hypersensitivity—Carmustine—brain cancer	0.000241	0.00586	CcSEcCtD
Metyrosine—Nausea—Hydroxyurea—brain cancer	0.00024	0.00584	CcSEcCtD
Metyrosine—Asthenia—Carmustine—brain cancer	0.000234	0.0057	CcSEcCtD
Metyrosine—Hypersensitivity—Temozolomide—brain cancer	0.000232	0.00566	CcSEcCtD
Metyrosine—Asthenia—Temozolomide—brain cancer	0.000226	0.00551	CcSEcCtD
Metyrosine—Diarrhoea—Carmustine—brain cancer	0.000223	0.00544	CcSEcCtD
Metyrosine—TH—Metabolism—BSG—brain cancer	0.00022	0.00514	CbGpPWpGaD
Metyrosine—Fatigue—Etoposide—brain cancer	0.000218	0.0053	CcSEcCtD
Metyrosine—Diarrhoea—Temozolomide—brain cancer	0.000216	0.00526	CcSEcCtD
Metyrosine—Feeling abnormal—Etoposide—brain cancer	0.000208	0.00507	CcSEcCtD
Metyrosine—Vomiting—Carmustine—brain cancer	0.000208	0.00505	CcSEcCtD
Metyrosine—Gastrointestinal pain—Etoposide—brain cancer	0.000206	0.00503	CcSEcCtD
Metyrosine—Headache—Carmustine—brain cancer	0.000205	0.00498	CcSEcCtD
Metyrosine—Vomiting—Temozolomide—brain cancer	0.000201	0.00488	CcSEcCtD
Metyrosine—Urticaria—Etoposide—brain cancer	0.000201	0.00488	CcSEcCtD
Metyrosine—Abdominal pain—Etoposide—brain cancer	0.0002	0.00486	CcSEcCtD
Metyrosine—Headache—Temozolomide—brain cancer	0.000198	0.00481	CcSEcCtD
Metyrosine—Nausea—Carmustine—brain cancer	0.000194	0.00472	CcSEcCtD
Metyrosine—TH—Metabolism—IDH1—brain cancer	0.000189	0.00442	CbGpPWpGaD
Metyrosine—Nausea—Temozolomide—brain cancer	0.000187	0.00456	CcSEcCtD
Metyrosine—Hypersensitivity—Etoposide—brain cancer	0.000186	0.00453	CcSEcCtD
Metyrosine—Asthenia—Etoposide—brain cancer	0.000181	0.00441	CcSEcCtD
Metyrosine—Diarrhoea—Etoposide—brain cancer	0.000173	0.00421	CcSEcCtD
Metyrosine—Vomiting—Etoposide—brain cancer	0.000161	0.00391	CcSEcCtD
Metyrosine—TH—Circadian rythm related genes—TP53—brain cancer	0.00016	0.00374	CbGpPWpGaD
Metyrosine—Headache—Etoposide—brain cancer	0.000158	0.00385	CcSEcCtD
Metyrosine—Nausea—Etoposide—brain cancer	0.00015	0.00365	CcSEcCtD
Metyrosine—TH—Metabolism—ENO2—brain cancer	0.00015	0.00349	CbGpPWpGaD
Metyrosine—TH—Metabolism—PIK3CG—brain cancer	6.87e-05	0.0016	CbGpPWpGaD
